Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
147.78
-0.95 (-0.64%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Masimo Employees
Masimo had 3,600 employees as of December 28, 2024. The number of employees decreased by 200 or -5.26% compared to the previous year.
Employees
3,600
Change (1Y)
-200
Growth (1Y)
-5.26%
Revenue / Employee
$598,278
Profits / Employee
-$127,556
Market Cap
8.03B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 3,600 | -200 | -5.26% |
| Dec 30, 2023 | 3,800 | -200 | -5.00% |
| Dec 31, 2022 | 4,000 | 1,800 | 81.82% |
| Dec 31, 2021 | 2,200 | 200 | 10.00% |
| Dec 31, 2020 | 2,000 | 400 | 25.00% |
| Dec 28, 2019 | 1,600 | 100 | 6.67% |
| Dec 29, 2018 | 1,500 | 100 | 7.14% |
| Dec 30, 2017 | 1,400 | 157 | 12.63% |
| Dec 31, 2016 | 1,243 | -57 | -4.38% |
| Dec 31, 2015 | 1,300 | 100 | 8.33% |
| Dec 31, 2014 | 1,200 | -1,939 | -61.77% |
| Dec 28, 2013 | 3,139 | 273 | 9.53% |
| Dec 29, 2012 | 2,866 | 318 | 12.48% |
| Jan 1, 2011 | 2,548 | 151 | 6.30% |
| Dec 31, 2009 | 2,397 | 198 | 9.00% |
| Dec 31, 2009 | 2,199 | 460 | 26.45% |
| Dec 31, 2008 | 1,739 | 391 | 29.01% |
| Dec 29, 2007 | 1,348 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MASI News
- 2 days ago - Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 4 days ago - Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4 - Business Wire
- 16 days ago - Masimo to Host Investor Day on December 3, 2025 - Business Wire
- 18 days ago - In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones - Business Wire
- 4 weeks ago - Masimo Completes Sale of Consumer Audio Business to HARMAN International - Business Wire
- 4 weeks ago - HARMAN Completes Sound United Acquisition to Expand Premium Audio Leadership - Business Wire
- 5 weeks ago - New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs - Business Wire
- 6 weeks ago - Masimo Announces Expansion of Strategic Partnership with Philips - Business Wire